Loading...

INDIAGLYCO India Glycols Ltd US FDA Inspections Announcement

nd G

NDGL

India Glycols Ltd

(INDIAGLYCO)

2025 Announcement

Show Summary

Summary

GMP Certification Received

Compliance Certificate

Investor Call Scheduled

Record Sales Achievement

Postal Ballot Notice

Share Split Announced

Share Split Approved

Annual Compliance Report

Earnings Call Transcript

Earnings Call Available

Investor Presentation

Equity Shares Transfer

Earnings Call Reschedule

Board Meeting Outcome

Management Changes

Scheme Modification

Earnings Call Scheduled

Earnings Call Scheduled

USFDA EIR Received

Compliance Certificate

Capacity Expansion

Credit Rating Update

Ethanol Supply Allocation

Earnings Call Summary

Earnings Call Recording

Investor Presentation

Scheme of Arrangement

GST Order Intimation

Earnings Conference Call

Earnings Call Announcement

GST Order Issued

Sales Record Achieved

Office Relocation

Compliance Certificate

Management Change

Subsidiary Company

Share Disclosures

New Subsidiary Formed

GST Penalty Imposed

Earnings Call Transcript

Premium Alcobev Venture

Earnings Call Audio

Investor Presentation

New Subsidiary Formation

Earnings Call Notice

Earnings Call Announcement

Postal Ballot Notice

Management Change

Compliance Certificate

Capacity Expansion Update

Consultant Appointment

New Partnership

Director Changes

Credit Rating Update

Tax Demand Notices

Earnings Call Transcript

Newspaper Advertisement

Earnings Conference Call

Investor Presentation

Publication of Annual Gener...

Committee Formation

Dividend Tax Deduction

Certificate Submission

Capacity Enhancement Update

Newspaper Publication

Investor Presentation

Compliance Filing

Earnings Conference Call

Execution Update

Compliance Certificate

Order from Additional Commi...

Compliance Certificate Subm...

Management Resignation

Certificate Submission

Capacity Enhancement Update

Ethanol Capacity Boost

Credit Rating Revision

Newspaper Publication

Disclosure of Earnings Call...

Investor Presentation

Capacity Enhancement

Appointment and Capacity Ad...

Appointment and Capacity En...

Enhancement of Capacity at ...

Certificate Submission

Capacity Enhancement

Capacity Expansion

Disclosure of Penalty

Rescheduling of Analyst/Inv...

Investor Conferences

Meeting Schedule

Allocation of Ethanol Supply

Earnings Call Transcript

Investor Presentation

Management Appointments

Appointment of Director

Conference Call

Earnings Conference Call

Certificate Submission

Personnel Change

Transfer of Shareholding

Earnings Release

Tax Deduction on Dividend P...

Capacity Enhancement

Capacity Addition, Expandin...

Financial Statements

Financial Statements

Conference Call

Earnings Conference Call

Webcasts/Presentations

Financial Statements Disclo...

Conference Call

External Links:

Data:

India Glycols Ltd received a positive Establishment Inspection Report (EIR) from the USFDA on April 24, 2025, for its nutraceutical products and dietary supplements at its Dehradun plant, indicating adherence to global quality standards.

AI Assistant

India Glycols Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.